Insider Shareholders with Direct Ownership of Silverback Therapeutics, Inc. (SBTX)
This section provides a comprehensive overview of the insiders with direct ownership of Silverback Therapeutics, Inc. (SBTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Silverback Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Richard E Lowenthal
PRESIDENT AND CEO |
5,377,189 | 1,050,000 | 4,315,313 $0 | 4 |
Apr 19, 2024
Added 1.58%
|
Sarina Tanimoto
CHIEF MEDICAL OFFICER |
4,483,512 | 1,050,000 | 3,407,847 $0 | 4 |
Apr 23, 2024
Added 1.4%
|
Alexandria Venture Investments, Llc
> 10% Shareholder |
699,412 | 0 | 699,412 $0 | 1 |
Dec 08, 2020
Added 50.0%
|
874,347 | 743,896 | 210,346 $0 | 36 |
Dec 04, 2024
Reduced 6.56%
|
|
Justin Chakma
Chief Business Officer |
665,625 | 529,245 | 136,380 $0 | 20 |
Dec 13, 2024
Reduced 16.66%
|
Jonathan D Root
Director |
95,238 | 0 | 95,238 $0 | 1 |
Dec 08, 2020
Added 50.0%
|
Alexander A Fitzpatrick
Chief Legal Officer |
86,258 | 0 | 89,227 $0 | 2 |
Sep 29, 2023
Added 34.14%
|
Jonathan Piazza
Chief Financial Officer |
66,845 | 0 | 69,225 $0 | 3 |
May 02, 2022
Added 38.69%
|
Valerie Odegard
President and CSO |
61,639 | 0 | 61,639 $0 | 2 |
May 02, 2022
Added 42.32%
|
Vickie L Capps
Director |
9,523 | 0 | 61,576 $0 | 1 |
Dec 08, 2020
Added 13.39%
|
Naomi Hunder
Chief Medical Officer |
54,427 | 0 | 54,427 $0 | 2 |
May 02, 2022
Added 44.24%
|
Russ Hawkinson
Sr. Vice President of Finance |
36,073 | 0 | 37,251 $0 | 3 |
May 02, 2022
Added 43.2%
|
Brian Dorsey
Chief Operating Officer |
120,000 | 120,000 | 6,024 $0 | 8 |
Dec 12, 2024
Reduced 80.58%
|
Eric Karas
Chief Commercial Officer |
30,000 | 30,000 | 5,693 $0 | 8 |
Dec 04, 2024
Reduced 52.46%
|
Kathleen D. Scott
Chief Financial Officer |
25,000 | 25,000 | 4,949 $0 | 4 |
Oct 16, 2024
Reduced 71.64%
|